Key result
18F-FDG PET/CT detects rare synchronous adrenal, cardiac, and CNS involvement in aggressive B-cell lymphoma.
Why the study?
Adrenal involvement in non-Hodgkin lymphoma is uncommon and indicates adverse outcomes and CNS tropism, but synchronous adrenal, cardiac, and CNS involvement has not been previously documented by imaging.
Case Report (n=1)
This case provides the first imaging documentation via 18F-FDG PET/CT of a rare synchronous triad of adrenal, cardiac, and CNS involvement in aggressive B-cell lymphoma.
May support 18F-FDG PET/CT for occult extranodal staging in aggressive lymphoma; leaves open impact on survival and CNS prophylaxis.
Adrenal involvement in non-Hodgkin lymphoma is uncommon and is recognized as a marker of adverse outcomes and of tropism for the central nervous system (CNS). We report a 22-year-old man who presented with fever, weight loss, and abdominal pain, in whom whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) demonstrated a large FDG-avid right suprarenal mass with contralateral adrenal involvement, 10 metabolically active cerebral lesions with mass effect, and FDG-avid deposits in the right atrium and left ventricle, together with peritoneal, soft tissue, and osseous disease. Biopsy of a retroperitoneal lymph node confirmed aggressive B-cell non-Hodgkin lymphoma. Imaging raised the enumerated extranodal count from two to at least six, establishing Ann Arbor stage IVB disease with an International Prognostic Index (IPI) of 4 and a CNS-IPI of 5. The patient died before treatment could be initiated. To our knowledge, this is the first imaging documentation of synchronous adrenal, cardiac, and CNS involvement in aggressive B-cell lymphoma.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2026) conducted a case report in Aggressive B-cell non-Hodgkin lymphoma (n=1). 18F-FDG PET/CT was evaluated. 18F-FDG PET/CT imaging revealed a rare synchronous triad of adrenal, cardiac, and central nervous system involvement in a 22-year-old man with aggressive B-cell non-Hodgkin lymphoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: